TABLE 2

Patient comorbidity characteristics for the full population (All) and by cluster

AllCluster 1Cluster 2Cluster 3Cluster 4Cluster 5Cluster 6Cluster 7p-value
Subjects n20 1643386348850531600201725532067
Cardiovascular comorbidities %
 Systemic hypertension47.280.286.36.373.681.57.414.1<0.001
 Ischaemic heart disease9.114.512.20.711.228.31.91.9<0.001
 Status post myocardial infarction2.43.33.40.11.79.90.20.2<0.001
 Cardiac failure2.74.53.90.14.18.50.20.2<0.001
 TIA or stroke2.32.94.20.13.16.30.70.7<0.001
 Valvular heart disease1.41.91.90.11.94.40.60.4<0.001
 Left ventricular hypertrophy1.41.81.70.61.12.60.72.0<0.001
 Pulmonary hypertension0.50.70.800.61.500.3<0.001
Metabolic comorbidities %
 Hyperlipidaemia23.262.50.16.745.046.2137.4<0.001
 Diabetes, noninsulin dependent13.427.103.539.139.23.13.6<0.001
 Diabetes, insulin dependent2.44.800.45.89.00.40.6<0.001
 Hyperuricaemia3.39.400.75.09.01.10.3<0.001
Pulmonary comorbidities %
 Asthma5.74.85.83.412.45.45.47.5<0.001
 COPD5.78.66.52.96.410.53.23.8<0.001
 Respiratory failure0.80.90.80.21.41.40.80.6<0.001
Other comorbidities %
 Malignant disease2.00.71.504.75.74.01.9<0.001
 Inflammatory disease1.90.81.006.03.54.02.0<0.001
 Neurological disease4.82.23.2010.19.114.72.2<0.001
 Gastrointestinal disease8.62.12.802425.521.44.6<0.001
 Psychiatric disease9.53.26.0026.19.533.35.3<0.001

TIA: transitory ischaemic attack.